The programme allows for new or existing clients to increase the time or bandwidth they use by multiples of up to 10 to meet needs as they arise. The new program is available as an on-premise, hybrid or cloud-based solution.
In recent weeks, many organisations have exponentially increased their demand for video communication platforms.
Vidyo's track record of supporting large health organisations, as well as major financial corporations, government agencies and educational institutions, positions it as an ideal solution for rapidly evolving contingency plans.
Specifically, the Vidyo Telehealth solution enables clinics and hospitals to protect front-line staff and patients by supporting self-isolation and quarantine scenarios, and ensures clinicians, nurses and physicians can provide remote diagnoses and treatments, often with existing technology.
Vidyo enriches people's lives by embedding real-time video into digital communications in the moments that matter most.
Millions of people around the world connect visually every day through Vidyo's secure, scalable technology and cloud-based services.
Its patented platform integrates with virtually any application environment, network and device to deliver the highest quality experiences that strengthen teams, build trust, solidify relationships, and improve quality of life.
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix
Organon to sell JADA System to Laborie for up to USD465m
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Oticon launches Oticon Zeal, a discreet, fully featured in-the-ear hearing aid
Halozyme Therapeutics announces Q3 2025 release date
Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia